ID: ALA4869208

Max Phase: Preclinical

Molecular Formula: C22H18FN5O2

Molecular Weight: 403.42

Molecule Type: Unknown

Representations

Canonical SMILES:  NC(=O)c1ncn2c(NCc3c(F)ccc4c3CCO4)ncc(-c3ccccc3)c12

Standard InChI:  InChI=1S/C22H18FN5O2/c23-17-6-7-18-14(8-9-30-18)16(17)11-26-22-25-10-15(13-4-2-1-3-5-13)20-19(21(24)29)27-12-28(20)22/h1-7,10,12H,8-9,11H2,(H2,24,29)(H,25,26)

Standard InChI Key:  GHEFDAYKXXNPRU-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 403.42

Molecular Weight (Monoisotopic): 403.1445

AlogP: 3.18

#Rotatable Bonds: 5

Polar Surface Area: 94.54

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 3.81

CX LogP: 2.00

CX LogD: 2.00

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.53

Np Likeness Score: -0.99

References

1. Rej RK, Wang C, Lu J, Wang M, Petrunak E, Zawacki KP, McEachern D, Yang CY, Wang L, Li R, Chinnaswamy K, Wen B, Sun D, Stuckey JA, Zhou Y, Chen J, Tang G, Wang S..  (2021)  Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression.,  64  (19.0): [PMID:34613724] [10.1021/acs.jmedchem.1c01059]

Source

Source(1):

• Scientific Literature